2024.03.29 (금)

  • 흐림동두천 1.0℃
  • 흐림강릉 1.3℃
  • 서울 3.2℃
  • 대전 3.3℃
  • 대구 6.8℃
  • 울산 6.6℃
  • 광주 8.3℃
  • 부산 7.7℃
  • 흐림고창 6.7℃
  • 흐림제주 10.7℃
  • 흐림강화 2.2℃
  • 흐림보은 3.2℃
  • 흐림금산 4.4℃
  • 흐림강진군 8.7℃
  • 흐림경주시 6.7℃
  • 흐림거제 8.0℃
기상청 제공

경제

Medirune Co., Ltd. unveiled a new portable pain relief device at GMES 2012

NBC-1TV World News


[By NBC-1TV H. J Yook]Medirune Co., Ltd., (CEO Shin Won Kang, www.medirune.com) a company specialized in medical device, showcased a newly developed portable pain relief device at the 7th Gangwon Medical Equipment Exhibition (hereinafter referred to as “GMES 2012”), which was well received by a number of the domestic and foreign buyers.

GMES 2012, which was held for three days from September 20 to 22, was the exhibition in which approximately 50 of the medical device manufacturers and associated agencies in Gangwon-do and the buyers of more than the 80 companies from 35 countries in Europe, America, and Southeast Asia have participated; thus, it was organized as a meaningful event to sound out the future of the development of the medical device industry in Gangwon-do and the possibility of entry into the domestic and international markets.

Medirune Co., Ltd. unveiled “I-Rune Basic (tentative name)” at this exhibition, which is a new portable combination stimulator developed after the research and development of one year since the launch of I-Rune.

This product consists of the two channels; thus, it is possible to use the four patches simultaneously. It also has the important features that the menstrual pain mitigation mode (TENS) and the low frequency massage function have been embedded.

In particular, it is possible to use it conveniently without replacing another battery using the built-in battery. And it is portable anywhere at any time with the compact design of 4cm × 4cm size. It is expected to be released as a low-prevalence model.

Currently, the development of I-Rune Basic (tentative name) has been completed and it is about to be released. Upon completion of the items report at the Food and Drug Administration of South Korea, the company will embark in earnest on distributing the product to domestic and overseas companies.

“GMES 2012 was a good opportunity for the technology and quality of the product to get evaluated before the launch,” Shin Won Kang, CEO of Medirune Co., Ltd., said. “In particular, the product was well received by the domestic companies. Also, the overseas buyers from Canada, China, Europe, etc. have shown interests in the product. Therefore, we plan to embark on both product launch and entry to overseas markets at the same time.”



배너

관련기사


배너
배너
배너
배너
배너
배너
배너
배너
배너
배너
배너
배너